Results 31 to 40 of about 243,754 (245)

Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach

open access: yesInternational Journal of Molecular Sciences, 2023
Idiopathic membranous nephropathy (IMN) is a pathologically defined disorder of the glomerulus, primarily responsible for nephrotic syndromes (NS) in nondiabetic adults. The underlying molecular mechanisms are still not completely clarified.
Paolo Previtali   +11 more
semanticscholar   +1 more source

Phospholipase A2 Receptor Antibodies and Clinical Prognosis in Patients with Idiopathic Membranous Nephropathy: An Updated Systematic Review and Meta-Analysis

open access: yesKidney & Blood Pressure Research, 2023
Background: Idiopathic membranous nephropathy (IMN) is the most common form of primary nephrotic syndrome in adults. Antibodies against the M-type phospholipase A2 receptor (PLA2R-ab) are considered as diagnostic biomarkers of IMN.
Jialing Zhang   +3 more
semanticscholar   +1 more source

Preliminary study on the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A single-centre experience

open access: yesFrontiers in Endocrinology, 2023
Objective To investigate the efficacy of rituximab in the treatment of idiopathic membranous nephropathy (IMN). Methods A total of 77 patients with IMN diagnosed in both our hospital and other hospitals were included in this study; the patients were ...
Ping-bo Chen   +7 more
semanticscholar   +1 more source

Update on New Antigens in the Pathogenesis of Membranous Nephropathy [PDF]

open access: yes, 2022
Previously, membranous nephropathies were divided into primary and secondary categories when the exact mechanism or pathogenetic factor were unknown. Approximately 70% accounted for primary membranous nephropathies.
Aris Tsalouchos, Maurizio Salvadori
core   +1 more source

Acute kidney injury in patients with idiopathic membranous nephropathy: influencing factors and prognosis

open access: yesRenal Failure, 2023
Aim Idiopathic membranous nephropathy (IMN) is a common type of nephrotic syndrome, and is associated with acute kidney injury (AKI). We investigated the association of multiple variables with AKI in patients with IMN.
Zhen-Zhou Li   +11 more
semanticscholar   +1 more source

Clinical characteristics and prognosis of patients with idiopathic membranous nephropathy with kidney tubulointerstitial damage

open access: yesRenal Failure, 2023
Background To investigate the clinical and kidney pathological features and prognosis of idiopathic membranous nephropathy (IMN) with kidney tubulointerstitial damage (TID).
Mengyao Sun   +6 more
semanticscholar   +1 more source

Synthetic ACTH in High Risk Patients with Idiopathic Membranous Nephropathy: A Prospective, Open Label Cohort Study. [PDF]

open access: yesPLoS ONE, 2015
New therapeutic agents are warranted in idiopathic membranous nephropathy. Synthetic ACTH may be advantageous with reported remission rates up to 85% and few side effects.
Anne-Els van de Logt   +5 more
doaj   +1 more source

The cutoff value and prognosis of anti-PLA2R antibody for idiopathic membranous nephropathy: a single-center retrospective study in China

open access: yesRenal Failure, 2023
Serum anti-phospholipase A2 receptor (anti-PLA2R) antibody is used for the noninvasive diagnosis of idiopathic membranous nephropathy (IMN). However, the cutoff value of anti-PLA2R antibodies in IMN patients is debatable.
Hongxia Guo   +5 more
semanticscholar   +1 more source

Deep learning-based framework for the distinction of membranous nephropathy: a new approach through hyperspectral imagery

open access: yesBMC Nephrology, 2021
Background Common subtypes seen in Chinese patients with membranous nephropathy (MN) include idiopathic membranous nephropathy (IMN) and hepatitis B virus-related membranous nephropathy (HBV-MN). However, the morphologic differences are not visible under
Tianqi Tu   +6 more
doaj   +1 more source

Cyclophosphamide induced early remission and was superior to rituximab in idiopathic membranous nephropathy patients with high anti-PLA2R antibody levels

open access: yesBMC Nephrology, 2023
Rituximab (RTX) and cyclophosphamide (CYC) based treatments are both recommended as first-line therapies in idiopathic membranous nephropathy (IMN) by KDIGO 2021 guideline. However, the efficacy of RTX vs.
Cheng Xue   +10 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy